[1]YAN W,LIU Y,WEI YW.Emerging progress in understanding left-sided and right-sided colorectal cancer[J].Chin J Clin Oncol,2018,45(22):1155-1159.[阎伟,刘洋,魏云巍.左右半结肠癌研究进展[J].中国肿瘤临床,2018,45(22):1155-1159.]
[2]Li J,Zhang Y.Current experimental strategies for intracellular target identification of microRNA[J].ExRNA,2019,1(1):6.
[3]Gloria B,Claudia C,Isabella C.MicroRNAs as biomarkers for diagnosis,prognosis and theranostics in prostate cancer[J].International Journal of Molecular Sciences,2016,17(3):421.
[4]Song B,Wang Y,Kudo K,et al.miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit[J].Clinical Cancer Research,2008,14(24):8080-8086.
[5]Boni V,Bitarte N,Cristobal I,et al.miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation[J].Molecular Cancer Therapeutics,2010,9(8):2265-2275.
[6]Geng L,Chaudhuri A,Talmon G,et al.MicroRNA-192 suppresses liver metastasis of colon cancer[J].Oncogene,2014,33(46):5332-5340.
[7]Esquela Kerscher A,Slack FJ.Oncomirs-microRNAs with a role in cancer[J].Nature Reviews Cancer,2006,6(4):259-269.
[8]Fathullahzadeh S,Mirzaei H,Honardoost MA,et al.Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia[J].Cancer Gene Therapy,2016,23(10):327-332.
[9]Lian J,Jing Y,Dong Q,et al.miR-192,a prognostic indicator,targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma[J].Oncotarget,2016,7(3):2672-2683.
[10]Botla SK,Savant S,Jandaghi P,et al.Early epigenetic downregulation of microrna-192 expression promotes pancreatic cancer progression[J].Cancer Research,2016,76(14):4149-4159.
[11]Zacapalagómez AE,Navarrotito N,Alarcónromero L,et al.Ezrin and E-cadherin expression profile in cervical cytology:A prognostic marker for tumor progression in cervical cancer[J].Bmc Cancer,2018,18(1):349.
[12]Thomas J,Eichmann A.The power of VEGF (vascular endothelial growth factor) family molecules[J].Cellular and Molecular Life Sciences,2013,70(10):1673-1674.
[13]SHEN JH,WU X,ZENG SW,et al.Expression and significance of e-cadherin in colon carcinoma[J].Journal of Cancer Control and Treatment,2004,17(2):71-73.[沈金辉,吴璇,曾绍文,等.E-cad在结肠癌的表达及意义[J].肿瘤预防与治疗,2004,17(2):71-73.]
[14]Falchook GS,Kurzrock R.VEGF and dual-EGFR inhibition in colorectal cancer[J].Cell Cycle,2015,14(8):1129-1130.